We next used genome-scale CRISPR-Cas9 screening [44], and demonstrated that TP53 wild-type neuroblastoma cell lines displayed a higher genetic dependency of PPM1D as compared to TP53 mutated cell lines (Figure 2A,B and Table S1). The gene discussed is PPM1D; the disease is neuroblastoma.